We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 11 JANUARY 2005
TRIPS: The Post-Doha Divide - Issues for LDCs
PharmAlliance
TRIPs, the intellectual property component of the Uruguay round GATT Treaty, gave rise to an acrimonious debate between the developed countries and less developed countries (LDCs). On one side, business interests in the developed world claimed large losses from the imitation and use of their innovations in LDCs.
IndiaFood, Drugs, Healthcare, Life Sciences



